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Coagulation factor XIII polymorphisms and the risk of
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Summary l he ineonsistent tindmgs among assonation
studies thcil have e\ammed the relationship belween laitor
\IIIA Val34Leu and thrombosis ma\ he owing to ( 1 )
Population dulereiues in the prevalence öl other nsk fac-
tois thdl modiiv the assouation wi th Val34Ieu or (2)
hnkage disequihbnum wilh other luncliondl faUor \IIIA
pohinorphisms We theretoie perlormed genotvpmg for
factor \I1IA Val34Ieu rvr204Phe and Pro564Ieu in a
population-based studv ot myocardidl mldrction (MI) and
ischdemic stroke among white women <45-vecirs of dge
and 345 demographicdlh simildr controls dnd exammed
potcntidl interactions wilh other risk tactors The piesenee
öl the tdctor \1IIA Ieu34 dllele was assouated with a
shght decreased risk öl MI [odds rdtio (OR) = 0 80] thdl
was most pronounced among women with traditionell
tdidio\ds(.uldr nsk lactors Pdradoxitallv women carrymg
two copies ot the Leu34 allele had a nearly fourfold
increased nsk of ischaemic stroke relative to the Val34/
Vdl34 genotvpe Hetero?vgosity for factor XIIIA Phe2()4
was dssocidted with a milder increased nsk of ischaemic
stroke and analysis of d kindred with congemtal dysfibn
nogenaemia suggested that co-mhentance of the factor
XIIIA Phe204 allele may mcrease susceptibility to ischae
mic stroke Our results suggest that the factor XIIIA
Val34Leu vdriant may be associated with a decreased risk
of MI dinong young women with other nsk factors The
relationship ot factor XIIIA polymorphisms to cerebrovas
cular disease requires further study
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Coagulalion lactor XIII circulates ds a letramer composed ot
two catahtic A subumts and two carner B subumts dnd
participates durmg the hnal step ot the eoagulation cascade
Thrombin clcavage ot a 37-amino-acid N-termmal peptide
from factor XIIIA results in iormation öl activated fdctor
XIII a transglutammase that forms γ-glutamj Ι-ε-lysyl
bonds between adjcicent hbnn molecules The intermolec-
ular cross-lmking of flbrin äs well äs the cross-lmking of
cxj-antiplasmm to the übrin clot by activated lactor XIII
increases clol stabihty and resistdnce to fibnnolysis
(Mus?bek et al 1999)
A common Vdl34Leu polymoiphism öl the factor XIIIA
subunit results in an accelerated rdte öl conversion ot factor
XIII to dctridted tactor XIII bv thrombin and dn altered
cross-lmked fibiin clot structure (Ariens et al 2000 Balogh
Coricspondcnce Alexander!3 Reiner VI D Cdrdiovastuldr Health
RLsedrch Umt 1730 \hnor Avenue Suite 1360 VSR9 Bo\
3SSOSO Seattle WA 9S101-144S USA l· mail apremer(«
u \\ ashmglon cdu
et al 2000 Trumbo & Maurer 2000 Wartiovaara d «/
2000) In some epidemiological studies the Leu34 allele hcis
been assouated with decreased risk of myotardial infarclion
(MI) (Kohler et al 1998 Wartiovaara et al 1999 Hcimo
et al 2000) and ibchaemic stroke (Elbaz et al 2000) hui
other studies have found no association (Canavy et al 20(10
Corraletnl 2000) We hypothesized two possible reasons lor
these mconsistent findmgs Tirst the association öl Iciclur
XIIIA Val34Leu with decreased risk of arterial thrombotu
disease may be demonstrable only withm certdin popuKi
tions such äs younger mdividuals or those with υΐ1κΓ
genetic or dcquired nsk factor(s) that operate at least in pari
through the coagulation/flbnnolytic System Second \ a l 5 4
Leu is in partial hnkage disequihbnum with other Iciuw
XIIIA coding sequence polymorphisms (Kohler et al 1494·1
Reiner et al 2001a) that contnbute to phenotypic \aruition
m lactor XIII (Anwar et al 1999 Gallivan et al 1999 s.iln
et al 2000) Thus association studies that examim onl\
Vdl 34Leu do not account tor the possible confoundmu c Hi"
öl these other lactor XIIIA variants
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Γο test these hypothescs we exdmmed the association
bctween three functional factor XIIIA polymorphisms
( \ a l 3 4 I e u Tyr204Phe and Pro564Leu) and the nsk of
\II and ischaemic stroke in women under 45 vears of age
As we previously demonstrated the potential importance öl
the mteractions between several mhented prothrombotic
\anants (factor V Arg506Gln prothrombm G20210A
pldtelet glycoprotem Ilb Ile843Ser and platelet glycoprotem
la C807T) and traditional cardiovascular nsk factors in this
study populaüon (Rosendaal et al 1997ab Reiner et al
2000 2001b) we also explored the factor XIIIA polymor-
phisms in the context of gene environment and gene-gene
mteraction
PATIENTS AND METHODS
and data iollection Because of the rare
occurrence of artenal thrombotic disease in young women
we designed a population-based case-control study thal
mcluded two case groups (acute MI and ischaemit stioke)
tompared with demographically similar control subjects free
of cardiovascular or cerebrovascular disease (Rosendaal
et al 199 7a b) The study population consisted of women
] 8-44 years of age residmg in three contiguous counties in
western Washington state between 1991 and 1995 which
represented approximately 2 2 million women-years at nsk
MI and ischaemic stroke cases were mitially identihed b\
chart review of discharge diagnoses from all 34 hospitals
and emergency medical Service mcident reports in the stud>
region The diagnosis öl MI was based on Symptoms
electrocardiographic changes and elevated cardiac en/ymes
Stroke was defined äs new focal neurological def i t i t (s) with
no other apparent cause lastmg >24 h and the classilica-
tion of artenal ischaemic stroke was based on revicw of
bram imagmg studies and lumbar puncturc results by the
study neurologist Six hundred and eighty-four ehgible
control subjects identifled by random digit dialhng were
frequency matched to the age distnbution öl the cases
Of the ehgible study subjects 107 out of 161 (66 5%)
patients with non-fatal MI 58 out of 84 (75 3%) patients
with non-fatal ischaemic stroke and 526 out oi 684
(76 9%) ehgible control subjects were willing to partiupate
m an m-person interview which mvolved ascertamment of
demographic charactenstics and traditional cardiovascular
nsk factors Smokers were defined äs subjects who reported
smokmg both currently and regularly (at least hve ciga
rettes per week for at least six consecutive months) Obesity
was defined äs body mass index (BMI) > 27 3 kg/nr A
woman was classified äs hypertensive diabetic or hyper-
cholesterolaemic if she reported ever rcceivmg the diagnosis
by a physician
Venous blood samples were collected into EDTA-treated
vacutamers from a subset oi the study participants (78 MI
cases 41 ischaemic stroke cases and 391 participatmg
control subjects) To mimmi/e the possibihty of confound
mg owmg to population admixturc we conhned our
analysis to the 68 MI cases 36 ischaemic stroke cases
and 345 control subjects with blood samples who were
white
J / /
XJJJ qcnotiipmq Genomie DNA samples were
prepared Irom blood leucoeytes äs descnbcd pievioush
(Rosendaal i t al 1997a b) Genotyping for the laetor XIII
Val34Ieu T}r204Phe and Pio5641 eu polymoiphisms the
faetor V Arg506Gln and prothrombm G20210A mutations
and the platelet ghcoprotem üb Ile843Sei and glveoprotem
la C807I polymorphisms weie peilormed bj pohmerase
chain leaction (PCR) ampliheation of genomie DNA fol
lowed by restnction fragment length polvmorphism (RFIP)
analysis äs previously descubed (Rosendaal it al 1997a b
Reiner et al 2000 2001 ab) I aboratories performing the
genotyping were bhnded to Ihe casc or tonlrol Status and
other characlenstits of the subjetts from whom the samples
were obtamed
Sioiisiiail iiiinli/sis Ihc association ot each facteir XIII
gcnotype wi th MI or stroke was examineel b\ logistie
regression adjusted toi age and expressed äs odds lalios (OR)
and 95% tonlidenee intervals (951/ CD (model A)
Homo/vgosity foi the eommon allele de \al34/Va!34
ryr2()4/ lvr204 or Pro564/Pro564) was used äs the
relerenee group m the icgrcssion models and the heteio
/ygous and rare homo/ygous genotypes were modelled
separatel} usmg dumm} \ anables We also fitted a multi-
vanate logistit modcl lhal mcluded all three laetor XIIIA
polvmorphisms simultaneouslj to adjust lor potential con-
founding owmg to hnkage disequihbrium (model B) Ihe
cxlent to which assotiations wi th faetor XIIIA genotypes
were modibed b> other medieal lifestyle or genetic eardio
\aseular nsk faetors were assessed through anahses strat-
ihed on thest other nsk lactois In these subgroup anahses
the three dumrm \ anables representing the eommon
homoA gous hetero/\ gous and rare homoTj gous gcnotv pcs
were eollapsed into a bmary variable based on post hoc
analvsis of the data Ι ο test for the piescnee öl interaelion
multipheatne terms were mtroduecd into Ihe logistie
regression model and the P-\alue was eomputed lor Ihe
hkehhood ratio test eompanng the model containing the
mteraction term with the model laeking Ihe interactiem
term All statistieal tesling was Iwo sided and perlormed at
the a= 005 level
/ ainihi siifdi/ In a separate analysis we peiformcd
genotyping for the three Iactor XIIIA polymoiphisms
among 14 familv members öl a kindred with eongemtal
dysfibnnogenaemia in whom a iathei and daughter had
suffcred isehaemie stroke at ages 57 and 42 vears
respectively fhis family was aseertaincd through a thiid
famih member who presented at age 40 years wilh
recurrent venous thrombo embolie disease and was found
to be hetero/ygous for a fibnnogen /-chain Arg275Cvs
mutation (Imenberger et al 2000) Informed tonsent was
obtamed for all iamilj studies usmg protoeols approved bj
the Human Subjects Committee at the l niversitv öl
Washington
RFS1I I S
o/ (/u studii s»/;;« (s
Ihe charactenstics of the MI cases ischaemic st ioke tascs
and eontrol subje t t s are summaii/ed in l able I Ihe mean
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Table I. (. 'haractenstics of myocard ia l mlarct ion l \11 1 cascs. ischat'mic stroke cases and control subjects.
Kchaeimc stroke cases
i i ^ 56
Controi subjects
n = 345
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age of the stucly subjects was 38-0 years. and ranged from
IcS to 44 years, The majority of the women were premeno-
pausal and were not current users of oral contraceplives.
Traditional atherosclerotic risk factors such äs smoking.
obcsity. hypcrlcnsion und diabetes were more eommon
among both Ml patienls and ischaemic stroke patients than
controls. An increased prcvalence of hypercholesterolaemia
was conlined to the MI cases.
Uaclor XIIIA polfimorphisins und risk of Ml
The Proportion of individuals carrying at least one copy of
the Leu 34 allele was slightly lovver among MI patients
( 5 9 - 7 % ) lhan among eontrol subjects (45-8%) (Table I I ) .
However. the confidence intervals around the MI risk
estimates for the Yal34/Leu34 genolype (odds ratio.
()R = 0-80) and the Len34/Leu34 genotype (OR = 0-77)
were compatible wilh the null hypothesis öl' no association
(model A). As indicated in Table II model B, the estimates
of Ml risk associated with each Val34Leu genotype were
essentially unchanged aller multivariate adjustment for
the factor XIIIA Tyr204Phe and Pro564Leu polymor-
phisms. The age-adjusled OR associated with carrying at
least one copy of the Leu34 allele compared with the
Val34/Val34 genotype was 0-80 (95%CI 0-47-1-37).
Among the eontrol subjects. current smoking was slightly
more eommon among the Leu34-positive women (26%)
than the Leu34-negative women (17%), but the distribu-
tion ofother traditional cardiovascular risk factors (obesity,
hypertension. diabetes. hypercholesterolaemia. menopausal
Status) diel not differ according to the presence or absence
of the factor XIIIA Leu34 allele (data not shown). There
was no association belween either the factor XIIIA
Tyr204Phe or Pro564Leu polymorphisms and risk of MI
(Table II).
Table II. Fuctor Κ1Ι1Λ genotypes in myocardial infarction (MI) cases. Lschaemic stroke cases and Controls.
Val34Leu

















2 1 ( 6 - 1 )
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218 ( 6 3 - 2 )
1 1 5 ( 3 3 - 3 )
































































*Model A is adjusted for age only.
t.Model B is adjusled for age and the tvvo remaining l'aclor Χ11ΙΛ polymorphisms.
OR. odds ratio: CI. conlidence interval. Reference group for OR is women homozygous for the more eommon allele (i.e. Val34/Val34
Tyr204/Tyr204 or Pro564/Pro564).
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One of our a priori hypotheses was that the decreased risk
of MI associated with factor XIIIA Val34Leu may be confined
to individuals with other risk factors. Therefore. the risk of
Ml associated with carrying at least one copy of the factor
XIIIA Leu34 allele was stratifled according to subgroups
defined by traditional cardiovascular risk factors or genetic
inutations that have been previously associated with MI risk
in this study population (Rosendaal et a!, 1997a.b; Reiner
et al, 2001b) (Table III). These data suggest that the
decreased risk of MI associated with the Leu34 allele may
be confined to subgroups of women with other risk factors
(cigarette smoking, obesity. hypertension, menopause or the
glycoprotein Ilb Ser843 variant). The risk of MI associated
with carrying at least one copy of the Leu34 allele was
particularly low in the subgroup of women who were obese
(age-adjusted OR = 0-33, 95%CI 0-13-0-83). The P-value
for interaction between factor XIII Val34Leu and obesity was
0-006. The P-values for the interactions between factor XIII
and the remaining risk factors in Table III were all > 0-05.
There was no evidence of interaction between Val34Leu and
either the Tyr204Phe and Pro564Leu polymorphisms on
the risk of MI (data not shown).
Factor XIIIA polymorphisms and risk of ischacmic streike
In contrast to the MI cases. the proportion of subjects who
carried one or more copies of the Leu34 allele was higher
among the ischaemic stroke cases than the control subjects
(Table II). There was a particularly high prevalence of the
Leu34/Leu34 genotype among women with ischaemic
stroke (16-7%) compared with the control subjects (5-8%).
This resulted in a nearly fourfold increased risk of ischaemic
stroke associated with the Leu34/Leu34 genotype compared
with women with the Val34/Val34 genotype. The age-
adjusted OR associated with the Leu34/Leu34 genotype
compared with women who carried either the Val34/VaB4
or VaB4/Leu34 genotypes was 3-33 (95%CI 1-23-8-98).
The factor XIIIA Tyr204/Phe204 genotype was associated
with a ~twofold increased risk of ischaemic stroke. but the
confldence interval around this risk estimate was wide
owing to the relatively low prevalence of the Phe204 allele.
Table III. Factor XIII Leu34 in myocardial infarction (MI) cases and controk stratified by other environmental



























































































































OR, odds ratio; CI, conüdence interval. Data are missmg on obesity in two controk. on diabetes in one
control. on hypercholesterolaemia in three controls. and on factor V Leiden or prothrombin G20210A in three
Controls.
*OR and 95% CI calculated for presence of Leu allele (homo'/ygous or heterozygous) compared with Val/Val
genotype, and adjusted for age.
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and compatible with the absence of an association. The
distribution of factor XIIIA Pro564Leu genotypes did not
differ between ischaemic stroke cases and controls. As with
the MI cases. there was no evidence that the risk estimate
for stroke associated with any individual factor XIIIA
polymorphism was significantly altered by multivariate
adjustment for the two remaining polymorphisms (Table II,
model B).
We have previously observed an association between risk
of ischaemic stroke among these young women and the 0.1
integrin C807T polymorphism of the platelet collagen
receptor (Reiner et al. 2000). When stratifled according to
genotypes defined by the a.2 integrin C807T polymorphism,
all six factor XIIIA Leu 3 4 homozygous ischaemic stroke
cases were carriers of the «^ integrin 807T allele. Thus, the
increased risk of ischaemic stroke associated with the factor
XIIIA Leu34/Leu34 genotype was present among 807T
carriers, but not among women with the 807C/C genotype
(P-value for interacüon =0-10).
Factor XIIIA Phe204 co-inheritancc and ischaemic stroke
in a family with congenital dysflbrinogenaemia
The potential role of the factor XIIIA Ty204Phe polymor-
phism in occurrence of ischaemic stroke was further
supported by genotype analysis of 14 family members from
a previousiy described kindred with congenital dysfibrino-
genaemia caused by an Arg275Cys mutation within the
gene encoding the flbrinogen γ-chain (Linenberger et al,
2000). A man who suffered a fatal ischaemic stroke at age
57 years and his daughter who suffered a non-fatal arterial
ischaemic stroke at age 42 years were both doubly hetero-
zygous for the rare γ-fibrinogen Arg275Cys mutation and
the common factor XIIIA Phe204 variant. The wife of the
man who died of ischaemic stroke at age 57 years was
homozygous wild type at both the γ-fibrinogen and factor
XIIIA loci. In addition to the affected daughter, the couple
had two other children. A 41-year-old son who has suffered
recurrent venous thrombo-embolic events also co-inherited
the father's γ-fibrinogen Arg275Cys mutation and factor
XIIIA Tyr204Phe variant, but has not suffered any arterial
thrombotic events while being maintained on therapeutic
warfarin since the age of 40 years. A 37-year-old daughter
had inherited the father's factor XIIIA Phe204 allele but not
the γ-fibrinogen mutation, and was clinically unaffected.
The affected father had five siblings (ranging in age from 55
to 64 years), two of whom were heterozygous for the
γ-fibrinogen mutation, but none carried the factor XIIIA
Phe204 allele. One of the five siblings was a man who was
homozygous wild type at both the γ-fibrinogen and factor
XIIIA loci. but suffered an acute MI at the age of 60 years in
the setting of traditional cardiovascular risk factors (smok-
ing, hypertension) and documented coronary atherosclero-
sis. The affected father's five siblings had a total of four
children (age ränge 34-45 years); two carried the
γ-fibrinogen mutation, none carried the factor XHI
Phe204 allele, and all were clinically asymptomatic. Thus,
two of three family members who carried both the
γ-fibrinogen mutation and the factor XIIIA Phe204 allele
had suffered early onset ischaemic stroke, while the third
member (who had suffered multiple venous thrombotic
events) was chronically treated with warfarin. In contrast,
none of the 11 family members who either carried the
γ-fibrinogen mutation alone or were homozygous wild type
at both loci, have developed ischaemic stroke (Table IV).
There was no evidence of a relationship between genotype
at either the factor XIIIA Val34Leu or Pro564Leu loci and
occurrence of ischaemic stroke among members of this
family (data not shown).
DISCUSSION
Our Undings from a population-based association study of
women under the age of 45 years provide further Support
for the importance of genetic Variation of factor XIII in
susceptibility to arterial thrombotic disease. Overall, women
who carried at least one copy of the factor XIIIA Leu 34
allele had a slightly decreased risk of MI, and the decreased
risk was most pronounced among women with other risk
factors. Unexpectedly, women who carried two copies of the
Leu 3 4 allele had a nearly fourfold increased risk of
ischaemic stroke. We also provide evidence that co-inher-
itance of the factor XIII Phe204 variant may increase the
risk of ischaemic stroke among subjects with congenital
dysfibrinogenaemia.
A decreased risk of MI associated with the factor XIIIA
Leu34 variant has been reported in studies from Great
Britain (Kohler et al, 1998), Finland (Wartiovaara et al
1999) and Brazil (Franco et al, 2000) involving predomi-
nantly middle-aged or young men, among whom the
reported ORs were in the ränge of 0-5-0-6. In contrasl.
other studies involving predominantly men from Southern
France (Canavy et al, 2000) and Spain (Corral et al, 20(101
found no association between the factor XIII Leu34 variant
and risk of MI. Our data suggest that the inconsistent results
© 2002 Blackwell Science Ltd, British Journal of Haematology 116: 3 76-W-
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among studies may be related to population differences in
the underlymg prevalence of other athero-thrombotic nsk
factors Franco et al (2000) also noted thdt the decreased
nsk of noo-fatal MI among relatively young inen and
women associated with factor XIIIA Leu34 was most
apparent m the presence of traditional cardiovascular nsk
factors such äs hypertension obesity dyshpidaemia and
diabetes compared with the absence of these nsk fdctors
The Bntish mvestigators observed thdt the decreased nsk of
MI associated with factor XIIIA Val34Leu was only present
among patients who did not carry the PAI l 4G/4G
genotype (Kohler et al 1998) or did not have features of
the msulin resistance syndrome (Kohler et al 1999b)
Stratification of the nsk of MI associated with factor XIIIA
Val34Leu accordmg to other nsk factors was not performed
m the two negative studies from Southern France and Spam
(Canavy et al 2000 Corral et al 2000) Perhaps the
decreased nsk of MI associated with factor XIIIA Leu34
is chnically non-apparent in Mediterranean populations
already protected from arterial thrombotic disease by other
mechanisms (Muszbek 2000) Taken together these results
suggest that the decreased nsk of MI associated with factor
XIII Val34Leu is modifled by other genetic and environ
mental determmants of cardiovascular nsk
We also hypothesized that the mconsistent flndmgs
among studies that have exammed the relationship of
Val34Leu with nsk of thrombotic disease could arise from
partial linkage disequilibnum between Val34Leu and
another factor XIIIA polymorphism that is the actual
'causative' mutation This scenario would be particularly
likely if the strength of Imkage disequilbnum between the
two sites vanes among different ethnic populations Addi
tional factor XIIIA genotype analyses from our study dnd
the study of Kohler et al (1999a) provide no evidence that
the association between VaI34Leu and risk of MI is
confounded by Imkage disequilibnum with severdl other
known factor XIIIA codmg sequence polymorphisms
Our Unding of a possible association between Leu 3 4
homozygosity and increased risk of ischaemic stroke at a
young age was unexpected and appears to contradict the
presumed 'antithrombotic' effect of this genetic vanant
based on previous studies of MI äs well äs a recent French
study that indicated that carrymg at least one copy of the
Leu34 allele was associated with a decreased nsk of
ischaemic stroke (OR = 0 58 95%CI = 044-0 75) (Elbdz
et al 2000) Because of our small sample size owmg to the
rare occurrence of ischaemic stroke in young women it is
possible that our findmg represents a chance or spunous
result It is unhkely that our results are biased by the
exclusion of fatal cases because the case fatahty rate for
ischaemic stroke in our study population was only 10%
Corral et al (2000) reported no association between Leu 3 4
and nsk of ischaemic stroke but it is mterestmg to note thdt
the prevalence of the Leu34 allele in their study was higher
among stroke cases (42 3%) than among controls (31 7%)
Fmally the increased risk of ischaemic stroke associdted
with the Leu34/Leu34 genotype m our study was present
only among young women who carned the cx> mtegrin
80 7T dllele d prothrombotic genetic susceptibility marker
thdt has been associated with the occurrence of ischaemic
stroke dt d young dge (Carlsson et al 1999 Reiner et al
2000) This possible gene-gene interaction requires conhr-
mation m larger studies of ischaemic stroke in young adults
The Tyr204Phe polymorphism of factor XIIIA results in
reduced factor XIII specific flbnn cross-lmking activity dnd
has been associated with increased risk of recurrent
miscarriage (Anwar et al 1999) Our results suggest d
possible associdtion with incredsed risk of early onset
ischaemic stroke which requires conflrmation in larger
studies We also descnbe co-mhentance of factor XIIIA
Phe204 with a rare flbrmogen γ chain Arg275Cys muta-
tion m two family members who suffered ischaemic stroke
and in a third family member with recurrent venous
thrombo-embohc disease The fibrinogen γ chain Arg
275Cys mutdüon results in an abnormal fibrin clot struc-
ture and increased clot resistance to fibrinolysis but appedrs
to be dssocidted with climcdl thrombo-embohc events only
dmong subjects who cdrry additional genetic prothrombotic
risk fdctors (Linenberger et al 2000 Siebenlist et al 2000)
A more common fibrinogen Thr312Ala α chdin mutation
thdt involves a region important for factor XHI-dependent
cross-hnkmg hds been dssocidted with venous dnd drterial
thrombo-embohc disease and an mterdction hds been
reported between α fibrinogen Thr312Ala and fdctor XIII
Val34Leu on the risk of pulmonary embohsm (Carter et al
1999 2000) Taken together these data suggest thdt fdctor
XIIIA polymorphisms wdrrdnt further investigation äs
possible genetic modihers oi disease susceptibility conferred
by other thrombophihc mutations
In conclusion our results suggest that the factor XIIIA
Val34Leu polymorphism is associated with decreased risk of
MI in young women with other cardiovdscular nsk factors
such äs obesity Larger sample sizes will be required to
formally lest the hypotheses of effect modification with
respect to specific genetic hfestyle dnd metabohc dthero
thrombotic risk fdctors Findlly the potentidl role of the
fdctor XIIIA Vdl34Leu and Tyr204Phe polymorphisms m
the occurrence of cerebrovasculdr disedse warrants further
mechamstic and epidemiological study of these mutations
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